Does GOLIMUMAB Cause Interstitial lung disease? 337 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 337 reports of Interstitial lung disease have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.5% of all adverse event reports for GOLIMUMAB.
337
Reports of Interstitial lung disease with GOLIMUMAB
0.5%
of all GOLIMUMAB reports
39
Deaths
163
Hospitalizations
How Dangerous Is Interstitial lung disease From GOLIMUMAB?
Of the 337 reports, 39 (11.6%) resulted in death, 163 (48.4%) required hospitalization, and 25 (7.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for GOLIMUMAB.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which GOLIMUMAB Alternatives Have Lower Interstitial lung disease Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN